glp-1 yerba mate supplements cannot replicate effects of agonists Yerba Madre Organic Yerba Mate

Westfall, E., Jeske, R

Network meta-analyses suggest that higher-dose semaglutide (1 mg and 2 mg weekly) and tirzepatide (a dual GIP/GLP-1 receptor agonist) demonstrate superior A1c reductions compared to other agents in the class, with mean reductions of 1.52.0% or greater from baseline

Hovedsageligt aktiv efter mltid

Health plans should work alongside PBMs and GLP-1 manufacturers to drive down costs, unlock rebates to further mitigate cost challenges and enhance drug commercialization (e.g., joint production partnerships, marketing partnerships)

One thing to keep in mind: fat triggers a slower GLP-1 response compared to protein or fiber